Context Therapeutics Inc is trading 6.4% down today at $1.60, extending a sharp multi-day decline amid light newsflow and recent high volatility.
- The move continues a significant downward trend from a price of $2.85 on May 29, 2026.
- There have been no fresh company announcements or major analyst actions reported this morning to clearly explain the additional downside.